Skip to main content
. 2013 Aug 21;8(8):e71827. doi: 10.1371/journal.pone.0071827

Figure 2. The assoication between preferred vaccine (Cervarix® vs. Gardasil® vs. no preference) and the reasons to choose vaccines (A to N).

Figure 2

(A: Stronger protection; B: Safety; C: Lower price; D: More HPV types; E: Protect against genital warts; F: Better antibody response; G: Long-lasting immunity; H: Cross-protection for other cancer-associated HPV types; I: Better adjuvant; J: Patients think it’s better; K: Practice management; L: Selected by the Government; M: Credibility of manufacturer; N: Comprehensive service of manufacturer). All comparisons among vaccine preference groups across reasons to choose vaccine categories (A to N) were statistically significant (p<0.05).